Viral recognition is mediated by different classes of PRRs (pattern-recognition receptors) among which the TLRs (Toll-like receptors) and the RLHs [RIG (retinoic-acid-inducible)-like helicases] play major roles. The detection of PAMPs (pathogen-associated molecular patterns) by these PRRs leads to the initiation of signalling pathways that ultimately result in the activation of transcription factors such as NF-κB (nuclear factor κB) and IRF-3 [IFN (interferon) regulatory factor-3] and IRF-7 and the induction of pro-inflammatory cytokines and type I IFNs. Viruses have evolved a fine-tuned mechanism to evade detection by the immune system or to interfere with the resulting signalling pathways. Here, we discuss viral evasion proteins that specifically interfere with TLR and/or RLH signalling.
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to the nucleic-acid-recognizing antiviral TLRs, TLR2 and TLR4 have been suggested to respond to several viral proteins (reviewed in [1] ).
Cytoplasmic antiviral PRRs (patternrecognition receptors)
It has been known for years that cells detect cytoplasmic dsRNA through PKR (dsRNA-dependent protein kinase), which in response inhibits host translation by phosphorylating the initiation factor eIF2α (eukaryotic initiation factor α). However, when two related DEXD/H-box RNA helicases RIG-I [RIG (retinoic-acid-inducible) protein I] and mda-5 (melanoma differentiation-associated gene-5) were described as novel cytoplasmic PRRs for viral dsRNA [2] , this enhanced our understanding of viral detection significantly. RIG-I and mda-5 are involved in the response to distinct viruses; for example, RIG-I detects Sendai virus, VSV, influenza A virus, Japanese encephalitis virus and Epstein-Barr virus, whereas mda-5 has been implicated in the response to picornaviruses. This is likely to be due to a different specificity for RNA ligands, which has recently become clearer (reviewed in [3] ).
In 2006, it was suggested that cytoplasmic B-form DNA can also elicit an IFN (interferon) response [3a, 3b] , and this year the protein DAI [DNA-dependent activator of IRFs (IFN-regulatory factors)] has been identified as a candidate DNA receptor in the cytoplasm [4] . It was demonstrated that DAI can respond to dsDNA (of mammalian, viral or bacterial origin) with the induction of an IFN response. Furthermore, siRNA (small interfering RNA) knock-down of DAI led to increased replication of a DNA virus (HSV) along with a reduced IFN response to this virus, whereas the response to an RNA virus (Newcastle disease virus) was unaffected [4] . This implicates DAI in the immune response against DNA viruses; however, it is possible that additional cytoplasmic DNA sensors are still awaiting discovery.
Figure 1 Viral evasion proteins targeting RLH-and/or TLR-induced signalling pathways
Simplified schematic diagram of the antiviral signalling pathways induced by RLHs and TLRs and a summary of the viral evasion proteins specifically targeting these pathways (as reviewed in [3] ). Viral proteins that are broad-range NF-κB or IRF inhibitors are excluded. ISRE, IFN-stimulatory response element.
Antiviral signalling pathways
Two key transcription factors that are activated during an antiviral immune response are NF-κB and the IRF family of transcription factors. Activation of the IRFs is crucial for the induction of type I IFNs, and although NF-κB also contributes to IFN induction, it is mainly required for the induction of pro-inflammatory cytokines. TLR3-and TLR4-induced IRF activation is mediated by TRIF, whereas MyD88 (myeloid differentiation factor 88) is sufficient for IRF activation induced by TLR7, 8 and 9 (reviewed in [5] ). TLR signalling to NF-κB proceeds mainly via MyD88, the IRAKs [IL-1 (interleukin-1) receptor-associated kinases] and TRAF-6 (tumour-necrosis-factor-receptor-associated factor-6). The signalling pathway emanating from RIG-I is still less well defined, but it involves a mitochondrial adaptor molecule Figure 1 ). The newly discovered DNA receptor DAI also appears to engage TBK1 for activation of IRF-3 [4] .
Intracellular viral evasion proteins
Viruses have evolved a range of mechanisms to interfere with detection by the innate immune system or the signalling pathways elicited in response to their detection. Some viral proteins specifically target certain PRRs or their downstream signalling pathways, while others have a broader range of action and interfere with NF-κB and/or IRF activation more generally. Recently, a couple of viral proteins have been described to prevent RNA detection through RIG-I and mda-5, e.g. the paramyxovirus V proteins, which bind to mda-5, and influenza virus NS1, which binds to RIG-I. Other proteins such as Ebola virus VP35 bind to the dsRNA and thereby prevent detection by RIG-I and also PKR. Hepatitis C virus expresses the protease NS3/4a, which cleaves TRIF and the RLH (RIG-like helicase) adaptor IPS-1 and thereby specifically targets and evades TLR3-and TLR4-as well as RLH-signalling (reviewed in [3] and summarized in Figure 1 ). Other examples for viral proteins that target specific PRR signalling pathways are the VACV (vaccinia virus) TLR antagonists A46 and A52. A46 contains a TIR (Toll/IL-1 receptor) domain, interacts with the host TIR adaptors and thereby disrupts TLR signalling to NF-κB and IRF-3 ( Figure 1 ) [6] . A52 interacts with the downstream TLR signalling molecules TRAF-6 and IRAK2 (Figure 1 ). Through its interaction with IRAK2, it inhibits TLR-induced NF-κB activation and interferes with the induction of pro-inflammatory cytokines. On the other hand, its interaction with TRAF-6 mediates p38 MAPK (mitogenactivated protein kinase) activation and induction of the antiinflammatory cytokine IL-10 [7, 8] . Apart from A46 and A52, VACV encodes a whole range of immunomodulatory proteins, including several NF-κB inhibitors, such as N1 [9] , K1 [10] and M2 [11] . Since all of these proteins independently contribute to virulence, they are not functionally redundant. It is possible that they come into play at different stages of infection or in different cell types; however, the details that distinguish their function need further elucidation. So far no poxvirus protein has been identified that specifically interferes with the RLH pathway. However, since poxviruses are DNA viruses that replicate in the cytoplasm, it is conceivable that they are detected by the RLH system and would hence have developed a counteracting mechanism.
What can we learn from viral evasion proteins?
Viral evasion proteins are highly evolved and therefore finetuned to target key aspects of the antiviral response. Studying evasion strategies of a particular virus can therefore provide insights into the immune response mounted against this virus, e.g. the involvement of specific PRRs. The discovery of A52 and A46 suggested that VACV benefits from disrupting TLR signalling and, indeed, it has since been suggested that VACV engages TLRs [12, 13] . It is likely that VACV and many other viruses trigger both TLRs and RLHs at different stages of infection and that they therefore possess a battery of inhibitory proteins targeting different PRRs or different aspects of their signalling pathways. Viral proteins can also point us towards interesting host molecules with an important function in antiviral immunity; for example, determining the targets of the HCV (hepatitis C virus) protease NS3/4a helped to place IPS-1 in the RLH pathway [14] . Furthermore, from the finding that cleavage of IPS-1 by NS3/4a releases it from the mitochondrial membrane, we learned that the mitochondrial attachment of IPS-1 is functionally important [15] . We would hope that such a detailed knowledge of the modulation of the host protein by the virus can eventually be exploited to design antiviral therapeutics and to give us an edge in the evolutionary battle against the virus. 
